LEDAGA gel 160 mcg/g tb 60 g

7680676150013 CH-67615 L01AA05 07.16.1.

Active substances:

LEDAGA gel 160 mcg/g tb 60 g
LEDAGA gel 160 mcg/g tb 60 g
LEDAGA gel 160 mcg/g tb 60 g
1 / 3
google

Details

Product number
6761501
CPT
-
Packaging group
60
Unit
g
Composition
chlormethinum 160 µg ut chlormethini hydrochloridum, diethylenglycoli monoethylicum aetherum, propylenglycolum 0.1757 g, alcohol isopropylicus, glycerolum, acidum lacticum, hydroxypropylcellulosum, natrii chloridum, mentholum racemicum, dinatrii edetas, E 321 0.0001 g, ad gelatum pro 1 g.

Articles (1)

Ledaga, Gel
Gel
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/10/2025
Patient information leaflet
Français
24/10/2025
Patient information leaflet
Italien
24/10/2025
Professional SmPC
Allemand
21/10/2025
Professional SmPC
Français
21/10/2025
Professional SmPC
Italien
21/10/2025

Detailed composition

Substance Quantity Type Category
chlormethinum
160.0 UG Substance Wirkstoff (Principe actif)
chlormethini hydrochloridum
- Substance WIZUS
diethylenglycoli monoethylicum aetherum
- Substance HNIDK
propylenglycolum
0.1757 G Substance HBESI
alcohol isopropylicus
- Substance HNIDK
glycerolum
- Substance HNIDK
acidum lacticum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
mentholum racemicum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
E 321
0.0001 G Substance HBESI

Reimbursement information

Public price
CHF 1689.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

RECORDATI AG

4057 Basel

Authorization information

Swissmedic authorization number
67615
Drug name
Ledaga, Gel
Galenic form
GELK
ATC Code
L01AA05
Authorization status
Z
Dispensation category
A
First authorization
28/09/2021
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
LEDAGA ist zur topischen Behandlung von kutanem T-Zell-Lymphom (MF-CTCL) des Typs Mycosis fungoides bei Erwachsenen indiziert.

Packaging details

Description (FR)
LEDAGA gel 160 mcg/g tb 60 g
Description (DE)
LEDAGA Gel 160 mcg/g Tb 60 g
Market launch
28/09/2021
Narcotic (BTM)
No
Buy us a coffee Explore the data